Chief Physician, M.D., Ph.D., Doctoral Supervisor, Member of Jiusan Society Administrative Deputy Director of Neurosurgery, Renji Hospital; Head of Skull Base Composite Tumor Specialty Group Specializes in minimally invasive surgical treatment of complex cranial tumors (acoustic neuroma, brainstem tumors) Personal Profile Engaged in clinical neurosurgery for over 20 years, with training and visiting experiences at the University of California, Hannover Medical University in Germany, and the Neurosurgery Center of Washington University in the United States. Recipient of multiple talent awards including the "Wang Zhongcheng Chinese Neurosurgery Physician Annual Award," "Minhang Leading Talent," "Outstanding Young Scholar" of Shanghai Jiao Tong University School of Medicine, "New Outstanding Young Scholar" of Shanghai Municipal Health Commission, and "Outstanding Young Scholar." Medical Expertise Full-process treatment of neurocritical care (severe traumatic brain injury, large-area cerebral infarction, aneurysm/arteriovenous malformation rupture hemorrhage), especially postoperative neurocritical care monitoring and postoperative rehabilitation treatment Minimally invasive surgical treatment of complex cranial tumors (acoustic neuroma, brainstem tumors) Minimally invasive personalized treatment of glioma Neuroendoscopic treatment of trigeminal neuralgia and hemifacial spasm Personal Experience 2009/09, Ph.D., graduated from Shanghai Jiao Tong University, supervised by Jiang Jiyao, internationally renowned neurotrauma expert, basic research and clinical treatment of severe traumatic brain injury and cerebrovascular accidents (large-area cerebral infarction, aneurysm rupture hemorrhage). 2012/10, Postdoctoral Fellow, Neurosurgery Research Center, University of California, Davis, supervised by Lyeth Bruce, President of the World Federation of Neurotrauma, engaged in basic research on traumatic brain injury. 2015/11, Visiting Scholar, International Neuroscience Institute (INI) Hannover, Germany, supervised by Helmut Bertalanffy, Chairman of the Education Committee of the World Federation of Neurosurgical Societies (WFNS), minimally invasive treatment of brainstem tumors. 2018/12, Visiting Scholar, Harborview Medical Center affiliated with the University of Washington, supervised by Professor Laligam Sekhar, world-renowned skull base neurosurgery master, surgical treatment of skull base tumors. 2019/03, Established the Neurosurgery Department at Renji Hospital Hangzhou Bay Campus, initially establishing subspecialties including neurocritical care, neuro-oncology, and neuro-spine, successfully treating a large number of patients with severe traumatic brain injury (severe traumatic brain injury and stroke), pioneering minimally invasive surgery for complex skull base tumors in the Hangzhou Bay area, promoting the integration of Renji Hospital Neurosurgery medical quality in the Yangtze River Delta. 2020/06, Led the Composite Tumor Group of Neurosurgery at Renji Hospital, carrying out minimally invasive treatment of complex skull base tumors, with an annual surgical volume of 600 cases. Professional Expertise Applying "mild hypothermia," "standard large trauma craniotomy," and "intracranial pressure monitoring" techniques in neurocritical care to improve treatment rates and prognosis. Applying a novel composite minimally invasive technique characterized by "endoscopy" combined with traditional "microscopy" to treat complex intracranial tumors (pituitary adenomas and meningiomas), achieving minimally invasive and efficient treatment while ensuring total tumor resection rate and surgical safety. Applying "subcapsular dissection technique" and "270° internal auditory canal opening technique" in acoustic neuroma resection, effectively improving the protection rate of facial and auditory nerves and reducing the incidence of postoperative facial paralysis. Applying intraoperative neuronavigation, MRI, awake surgery, brain functional mapping, and other minimally invasive neurosurgical techniques in glioma surgery. Completely resecting the tumor while reducing neurological function damage.